|
LUZP6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66289204628356E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.9960036108132E-15 |
| Normal-vs-Stage2 |
1.406210E-02 |
| Normal-vs-Stage3 |
9.16766662584223E-12 |
| Normal-vs-Stage4 |
6.46782627455877E-12 |
| Stage1-vs-Stage2 |
2.924100E-02 |
| Stage1-vs-Stage3 |
2.966800E-01 |
| Stage1-vs-Stage4 |
7.382200E-02 |
| Stage2-vs-Stage3 |
1.199930E-02 |
| Stage2-vs-Stage4 |
3.015700E-03 |
| Stage3-vs-Stage4 |
3.880800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.0991207943789E-14 |
| Normal-vs-AfricanAmerican |
5.86919999999713E-05 |
| Normal-vs-Asian |
3.72780029067599E-10 |
| Caucasian-vs-AfricanAmerican |
3.956800E-01 |
| Caucasian-vs-Asian |
5.790800E-01 |
| AfricanAmerican-vs-Asian |
2.138000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.00020000562517E-11 |
| Normal-vs-Female |
1.84041670792112E-12 |
| Male-vs-Female |
1.588010E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.54949403202909E-12 |
| Normal-vs-Age(41-60Yrs) |
3.08264525017421E-12 |
| Normal-vs-Age(61-80Yrs) |
2.8229000026414E-08 |
| Normal-vs-Age(81-100Yrs) |
5.042700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.881200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.585200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.605200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.189000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.196600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.815000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.682300E-02 |
| Classical-VS-Follicular |
2.876400E-02 |
| Classical-VS-Other |
3.779400E-01 |
| Classical-VS-Normal |
1.63968838506889E-12 |
| Tall-VS-Follicular |
1.504170E-03 |
| Tall-VS-Other |
9.378000E-01 |
| Tall-VS-Normal |
5.15829601255291E-11 |
| Follicular-VS-Other |
1.832190E-01 |
| Follicular-VS-Normal |
1.166970E-04 |
| Other-VS-Normal |
7.776100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.04060005057249E-09 |
| Normal-vs-N1 |
1.10911280160053E-13 |
| N0-vs-N1 |
1.864640E-03 |
|
|
